Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al
Case Number:
1:11-cv-07104
Court:
Nature of Suit:
Judge:
Firms
- Colucci & Umans
- Eversheds Sutherland
- Jones Day
- Kasowitz Benson
- Knobbe Martens
- Latham & Watkins
- Ropes & Gray
Companies
Sectors & Industries:
-
January 09, 2013
Purdue, Ranbaxy Settle IP Fight Over Generic Oxycontin
Ranbaxy Laboratories Ltd. has admitted to infringing three Purdue Pharma LP patents and agreed to waive possible antitrust claims under a deal to resolve litigation over the painkiller Oxycontin, which won approval from a New York federal judge Tuesday.
-
October 11, 2011
Purdue Sues Ranbaxy Again Over Generic OxyContin
Purdue Pharma LP accused Ranbaxy Pharmaceuticals Inc. of infringing three of its patents for OxyContin in a lawsuit made public Tuesday, marking Purdue's latest challenge to the generics maker's attempt to market its own version of the popular painkiller.